Загрузка...
Final Report of the First Refractory Germ Cell Tumor Treated with Sunitinib Malate
Patients with advanced germ cell tumors can be cured with cisplatin-based chemotherapy, but the outcome remains unsatisfactory for patients with relapsed disease, including those patients with refractory disease after bone marrow transplantation. Targeted therapies have changed the standard of care...
Сохранить в:
| Главные авторы: | , , , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
S. Karger AG
2009
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2914388/ https://ncbi.nlm.nih.gov/pubmed/20737043 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000260901 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|